Biomarin Pharmaceutical Inc. · NASDAQ:BMRN
Friberg Gregory R sold 3,281 Biomarin Pharmaceutical Inc. shares (Form 4)
Traded May 7, 2026 · Filed May 11, 2026
On May 7, 2026, Friberg Gregory R (EVP, Chief R&D Officer) sold 3,281 Biomarin Pharmaceutical Inc. shares at US$53.85 for US$177K, leaving 51,818 shares. Filed May 11, 2026 (Form 4).
- Sold
- 3,281 shares
- Price
- US$53.85
- Value
- US$177K
- Holding after
- 51,818 shares
- Trading plan
- No
- Role
- EVP, Chief R&D Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | Sale | 3,281 | US$53.85 | 51,818 | Direct |
Source
Related
- Biomarin Pharmaceutical Inc.
- Friberg Gregory R
- Biomarin Pharmaceutical Inc. shareholders
- Form 4 · Friberg Gregory R · Oct 1, 2026
- Form 4 · Plenge Robert M · Sep 14, 2026
- Form 4 · Davis George Eric · Sep 3, 2026
- Form 4 · Countouriotis Athena · Jun 4, 2026
- Form 4 · Walbert Timothy P · Jun 4, 2026
- Form 4 · Ho Maykin · Jun 4, 2026